Source - RNS
RNS Number : 1347L
Cambridge Cognition Holdings PLC
29 September 2016

29 September 2016

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')


Major contract wins for CANTAB Connect


The neuroscience company Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG), which develops and markets near patient technologies to facilitate early intervention and development of treatments for neurological disorders, today announces the signing of two major contracts using the Company's CANTAB Connect technology.


The contracts totalling US$3.67million (£2.82 million) are with US biopharmaceutical companies for late stage clinical trials and will contribute US$1.07 million (£0.82 million) to reported revenue in the second half of 2016. 


The award of the contracts was expected and so the outlook for the current year remains unchanged.  


Steven Powell, PhD, Chief Executive Officer, Cambridge Cognition: "Securing these contracts is further evidence of the concerted effort being made to accelerate revenue growth from our core businesses in Academic Research and Pharmaceutical Clinical Trials.  Not only do we expect to secure further business from core CANTAB Connect products such as those used in the above contracts, but also products such as CANTAB Recruit and Cognition Kit which we introduced into our product portfolio earlier this year."




Notes to editors

About Cambridge Cognition

Cambridge Cognition is an international neuroscience company which develops and markets near patient cognitive assessment products to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders.


For over 30 years the company's patented technology has advanced the assessment of cognition to accelerate the development of safe and effective treatments, improve patient outcomes and measure cognitive health throughout life.


Partners include the world's leading biotechnology and pharmaceutical companies, academic institutions and public-private healthcare providers.





Cambridge Cognition Holdings PLC

Steven Powell, Chief Executive Officer

Noah Konig, Director of Product Marketing and Communications

Tel: 01223 810 700

finnCap Ltd (NOMAD and Joint Broker)

Tel: 020 7220 0500

Geoff Nash / Simon Hicks

(Corporate Finance)

Alice Lane

(Corporate Broking)


Hybridan LLP (Joint Broker)

Claire Noyce

Tel: 020 3764 2341

(Corporate Broking)


This information is provided by RNS
The company news service from the London Stock Exchange